Verdict85/ 100
Ranked #8 · Grade BEditorial review
Hims & Hers review
Mass-market, app-first weight program with nationwide reach and consumer-grade polish.
Visit Hims & Hers Editorial review — no commercial relationship.
- Semaglutide
- $199/mo
- Tirzepatide
- Not disclosed
- Coverage
- All 50 states
- Brand-name
- Compounded only
The scorecard
Hims & Hers scored on our six published factors. See the methodology.
Real-world results86/100
Price honesty83/100
Prescriber access90/100
Formulary choice80/100
Cancellation fairness84/100
Member support86/100
What we like
- Nationwide
- Slick app experience
- Strong brand trust
The caveats
- Tirzepatide pricing not consistently disclosed
- Compounded supply has drawn regulatory scrutiny industry-wide
The verdict
Best for: People who want a familiar, app-driven consumer brand. Mass-market, app-first weight program with nationwide reach and consumer-grade polish.
Pricing, states and verification reflect Hims & Hers's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Hims & Hers's site. Not medical advice; see our disclosure.